Alzheimer's disease: one disorder, too many genes?

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Human Molecular Genetics

• Publication date

  2004-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/HMG/DDH077PMID 14764623
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diagnostic accuracy of alzheimer’s disease: A neuropathological study

  2009cited by this paper
• The 1239G/C polymorphism in exon 5 of BACE1 gene may be associated with sporadic Alzheimer's disease in Chinese Hans

  2004cited by this paper
• Tumour necrosis factor-alpha gene polymorphisms and Alzheimer's disease.

  2003cited by this paper
• Association between the HFE mutations and unsuccessful ageing: a study in Alzheimer's disease patients from Northern Italy.

  2003cited by this paper
• Amyloid-β peptide levels in brain are inversely correlated with insulysin activity levels in vivo

  2003cited by this paper
• Association of HFE mutations with neurodegeneration and oxidative stress in Alzheimer's disease and correlation with APOE

  2003cited by this paper
• Identification of multiple loci for Alzheimer disease in a consanguineous Israeli-Arab community.

  2003cited by this paper
• Association study between Alzheimer’s disease and genes involved in Aβ biosynthesis, aggregation and degradation: suggestive results with BACE1

  2003cited by this paper
• Increased frequency of a new polymorphism in the cell division cycle 2 (cdc2) gene in patients with Alzheimer's disease and frontotemporal dementia.

  2003influential reference
• Polymorphism in the BACE gene influences the risk for Alzheimer's disease

  2003cited by this paper
• Joint analysis of candidate genes related to Alzheimer's disease in a Spanish population

  2003cited by this paper
• The association of beta-site APP cleaving enzyme (BACE) C786G polymorphism with Alzheimer's disease.

  2003cited by this paper
• Tumor necrosis factor alpha polymorphism C-850T is not associated with Alzheimer's disease and vascular dementia in an Italian population.

  2003cited by this paper
• Specific BACE1 genotypes provide additional risk for late‐onset alzheimer disease in APOE ε4 carriers

  2003cited by this paper
• Ordered-subsets linkage analysis detects novel Alzheimer disease loci on chromosomes 2q34 and 15q22.

  2003cited by this paper
• Sample size calculations for population‐ and family‐based case‐control association studies on marker genotypes

  2003cited by this paper
• Using haplotype blocks to map human complex trait loci.

  2003cited by this paper
• Results of a high-resolution genome screen of 437 Alzheimer's disease families.

  2003cited by this paper
• The Genetics of Adult-Onset Neuropsychiatric Disease: Complexities and Conundra?

  2003cited by this paper
• Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease.

  2003cited by this paper
• Genetic variation in a haplotype block spanning IDE influences Alzheimer disease

  2003cited by this paper
• Insulin degrading enzyme (IDE) genetic variants and risk of Alzheimer's disease: evidence of effect modification by apolipoprotein E (APOE).

  2003cited by this paper
• Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo

  2003cited by this paper
• HSP70-2 (HSPA1B) is Associated with Noncognitive Symptoms in Late-Onset Alzheimer's Disease

  2003cited by this paper
• Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.

  2003cited by this paper
• Further evidence for role of a promoter variant in the TNFRSF6 gene in Alzheimer disease

  2003cited by this paper
• [Association between the A2 allele of the HLA system and age at onset of Alzheimer's disease].

  2003cited by this paper
• A second locus for very-late-onset Alzheimer disease: a genome scan reveals linkage to 20p and epistasis between 20p and the amyloid precursor protein region.

  2002cited by this paper
• Proposed guidelines for papers describing DNA polymorphism-disease associations

  2002cited by this paper
• The Structure of Haplotype Blocks in the Human Genome

  2002cited by this paper
• Age at onset in two common neurodegenerative diseases is genetically controlled.

  2002cited by this paper
• Candidate-gene approaches for studying complex genetic traits: practical considerations

  2002cited by this paper
• Polymorphisms of insulin degrading enzyme gene are not associated with Alzheimer's disease.

  2002cited by this paper
• Full genome screen for Alzheimer disease: stage II analysis.

  2002cited by this paper
• Confirmation of association between D10S583 and Alzheimer's disease in a case--control sample.

  2002cited by this paper
• Genetic association studies: genes in search of diseases.

  2002cited by this paper
• The BACE gene: genomic structure and candidate gene study in late-onset Alzheimer's disease

  2001cited by this paper
• Of replications and refutations: The status of Alzheimer’s disease genetic research

  2001cited by this paper
• Genetic analysis of case/control data using estimated haplotype frequencies: application to APOE locus variation and Alzheimer's disease.

  2001cited by this paper
• A novel method of two‐locus linkage analysis applied to a genome scan for late onset Alzheimer's disease

  2001cited by this paper
• Association study designs for complex diseases

  2001cited by this paper
• Genome-wide linkage disequilibrium mapping of late-onset Alzheimer’s disease in Finland

  2001cited by this paper
• Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease

  2001cited by this paper
• Genetic association studies

  2001cited by this paper
• Substantial linkage disequilibrium across the insulin-degrading enzyme locus but no association with late-onset Alzheimer's disease

  2001cited by this paper
• Role of apoe/Abeta interactions in the pathogenesis of Alzheimer's disease and cerebral amyloid angiopathy.

  2001cited by this paper
• Replication validity of genetic association studies

  2001cited by this paper
• Amyloid β secretase gene (BACE) is neither mutated in nor associated with early-onset Alzheimer's disease

  2001cited by this paper
• Amyloid beta secretase gene (BACE) is neither mutated in nor associated with early-onset Alzheimer's disease.

  2001cited by this paper
• Association studies using novel polymorphisms in BACE1 and BACE2

  2001cited by this paper
• Mutations in the open reading frame of the β-site APP cleaving enzyme (BACE) locus are not a common cause of Alzheimer's disease

  2001cited by this paper
• Apolipoprotein E and Alzheimer's Disease A Role in Amyloid Catabolism

  2000cited by this paper
• SNPing away at complex diseases: analysis of single-nucleotide polymorphisms around APOE in Alzheimer disease.

  2000cited by this paper
• Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus

  2000cited by this paper
• Evidence for genetic linkage of Alzheimer's disease to chromosome 10q.

  2000cited by this paper
• Inflammation and Alzheimer's disease.

  2000cited by this paper
• Identification of novel genes in late-onset Alzheimer's disease.

  2000cited by this paper
• The number of trait loci in late-onset Alzheimer disease.

  2000cited by this paper
• A full genome scan for late onset Alzheimer's disease.

  1999cited by this paper
• A genome survey for novel Alzheimer disease risk loci: results at 10-cM resolution.

  1998cited by this paper
• Complete genomic screen in late-onset familial Alzheimer's disease.

  1998cited by this paper
• Insulin-degrading Enzyme Regulates Extracellular Levels of Amyloid β-Protein by Degradation*

  1998cited by this paper
• Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12.

  1997cited by this paper
• Genetic evidence for the involvement of τ in progressive supranuclear palsy

  1997cited by this paper
• The role of heredity in late-onset Alzheimer disease and vascular dementia. A twin study.

  1997cited by this paper
• Evidence for major gene inheritance of Alzheimer disease in families of patients with and without apolipoprotein E epsilon 4.

  1996cited by this paper
• Accuracy of Clinical Diagnosis of Alzheimer Disease and Clinical Features of Patients with Non-Alzheimer Disease Neuropathology

  1996cited by this paper
• Apolipoprotein E and Alzheimer disease.

  1995cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper
• Histocompatibility antigens in Alzheimer's disease. A preliminary study.

  1981cited by this paper
• Histocompatibility antigens in Alzheimer's disease. A preliminary study.

  1980cited by this paper
• Histocompatibility Antigens in Alzheimer’s Disease

  1980cited by this paper
• A Twin Study

  1968cited by this paper
• Predictive value of a single diagnostic test in unselected populations.

  1966cited by this paper

• Monoclonal antibodies and aptamers: The future therapeutics for Alzheimer's disease

  2024cites this paper
• Epigenetic regulons in Alzheimer's disease.

  2023cites this paper
• Structural insight into the human SID1 transmembrane family member 2 reveals its lipid hydrolytic activity

  2023cites this paper
• The Potential of a Stratified Approach to Drug Repurposing in Alzheimer’s Disease

  2023cites this paper
• Calcium Signaling Regulated by Cellular Membrane Systems and Calcium Homeostasis Perturbed in Alzheimer’s Disease

  2022cites this paper
• Inorganic Polyphosphate, Mitochondria, and Neurodegeneration.

  2022cites this paper
• The functions of SID1 transmembrane family, member 2 (Sidt2)

  2022cites this paper
• Protein misfolding and related human diseases: A comprehensive review of toxicity, proteins involved, and current therapeutic strategies.

  2022cites this paper
• Targeting Systemic Innate Immune Cells as a Therapeutic Avenue for Alzheimer Disease

  2022cites this paper
• Stress and Alzheimer's Disease: A Senescence Link?

  2020cites this paper
• A deep belief network-based method to identify proteomic risk markers for Alzheimer disease

  2020influential citation
• APOE Polymorphism And Susceptibility To Dementia Of The Alzheimer's Type In The Indian Population

  2020cites this paper
• Cognitive Health of Nonagenarians in Southern Italy: A Descriptive Analysis from a Cross-Sectional, Home-Based Pilot Study of Exceptional Longevity (Cilento Initiative on Aging Outcomes or CIAO)

  2020cites this paper
• ICAM1 gene polymorphism in late-onset Alzheimer’s disease

  2019cites this paper
• Association of lectin-like oxidized low density lipoprotein receptor 1 (OLR1) polymorphisms with late-onset Alzheimer disease in Han Chinese.

  2018cites this paper
• APOE Gene Polymorphism in Patients with Alzheimer’s Disease in Iran

  2018cites this paper
• Skeletal muscle-specific Sidt2 knockout in mice induced muscular dystrophy-like phenotype.

  2018cites this paper
• Adenosine Receptors in Alzheimer’s Disease

  2018cites this paper
• Arctic A&bgr;40 blocks the nicotine‐induced neuroprotective effect of CHRNA7 by inhibiting the ERK1/2 pathway in human neuroblastoma cells

  2017cites this paper
• Combined association of Presenilin-1 and Apolipoprotein E polymorphisms with maternal meiosis II error in Down syndrome births

  2017cites this paper
• The Aβ oligomer eliminating D-enantiomeric peptide RD2 improves cognition without changing plaque pathology

  2017cites this paper
• Amyloid beta: structure, biology and structure-based therapeutic development

  2017cites this paper
• Relationship of polymorphisms and haplotype in interleukin-16 and adiponectin gene with late-onset Alzheimer’s disease risk

  2017cites this paper
• Is the Association Between Education and Cognitive Resilience Modified by Brain Weight and Cortical Atrophy

  2017cites this paper
• New clues on Sidt2 being a cation conducting protein in lysosomal membranes

  2017cites this paper
• Identification of Sidt2 as a lysosomal cation‐conducting protein

  2017cites this paper
• Peripheral Inflammation, Apolipoprotein E4, and Amyloid-β Interact to Induce Cognitive and Cerebrovascular Dysfunction

  2017influential citation
• A century of confusion in researching Alzheimer’s disease

  2016cites this paper
• Adrenomedullin Expression in Alzheimer's Brain.

  2016cites this paper
• Amyloid-beta immunotherapy: the hope for Alzheimer disease?

  2016cites this paper
• بررسی ارتباط پلیمورفیسمهای rs1131445 و rs4072111 ژن مسیر التهابی اینترلوکین 16 با بیماری آلزایمر دیررس در ایران

  2016cites this paper
• Late Onset of Alzheimer's Disease in Iranian Patients

  2016cites this paper
• TNF-alpha G308A polymorphism and the susceptibility to Alzheimer's disease: an updated meta-analysis.

  2015cites this paper
• Association of PS1 1/2, ACE I/D, and LRP C/T polymorphisms with Alzheimer's disease in the Chinese population: a meta-analysis of case-control studies.

  2015cites this paper
• GENETIC STUDY OF BIOMARKERS INVOLVED IN THE PROCESS OF AGING NEURODEGENERATION

  2015influential citation
• Protein Misfolding and Amyloid Formation in Alzheimer’s Disease

  2015cites this paper
• The Role of Oxidative Stress in Neurodegenerative Diseases

  2015cites this paper
• Association between polymorphisms in Interleukin-16 gene and risk of late-onset Alzheimer's disease.

  2015influential citation
• Proteostasis and Chaperone Surveillance

  2015cites this paper
• Beta amyloid-induced upregulation of death receptor 6 accelerates the toxic effect of N-terminal fragment of amyloid precursor protein.

  2015cites this paper
• Transcriptomics study of neurodegenerative disease: emphasis on synaptic dysfunction mechanism in Alzheimer's disease.

  2014cites this paper
• There are no differences in IL-6, CRP and homocystein concentrations between women whose mothers had AD and women whose mothers did not have AD.

  2014influential citation
• Oxidative damage in Alzheimer’s disease

  2014cites this paper
• Pharmacogenomics in Developing Countries

  2014cites this paper
• The bright future of Alzheimer’s disease pharmacotherapy

  2014cites this paper
• "Identificación de regiones clave en el proceso de agregación y citotoxicidad del péptido β-amiloide"

  2014cites this paper
• Application of anti-LRP/LR specific antibodies for the treatment of Alzheimer's disease

  2014cites this paper
• Protein misfolding and aggregation in Alzheimer's disease and type 2 diabetes mellitus.

  2014cites this paper
• Detecting amyloid biomarkers: Embodied risk and Alzheimer prevention

  2013cites this paper
• Olfactory Function : The Influence of Demographic, Cognitive, and Genetic Factors

  2013influential citation
• ALZHEIMER’S DISEASE Advances in Genetics, Molecular and Cellular Biology ALZHEIMER’S DISEASE Advances in Genetics, Molecular and Cellular Biology

  2013cites this paper
• Lack of association between COMT Val158Met polymorphism and late-onset Alzheimer's disease in Han Chinese.

  2013cites this paper
• Detecting amyloid biomarkers: Embodied risk and Alzheimer prevention

  2013cites this paper
• Author ' s response to reviews Title : Lack of association between Cathepsin D C 224 T polymorphism and risk of Alzheimer ' s disease : An update meta-analysis

  2013cites this paper
• [Genetics and Alzheimer's disease: a population at risk].

  2013cites this paper
• Characterization of proteins involved in the production of β-Amyloid peptides and tau hyperphosphorlation in Familial Alzheimer’s Disease

  2012cites this paper
• Sortilin‐related VPS10 domain containing receptor 1 and Alzheimer's disease‐associated allelic variations preferentially exist in female or type 2 diabetes mellitus patients in southern Han Chinese

  2012cites this paper
• Expression of the Newly Identified Gene CAC1 in the Hippocampus of Alzheimer’s Disease Patients

  2012cites this paper
• Association of PS1 Gene Polymorphisms with Alzheimer’s Disease in Chinese Population: A Meta-Analysis of Case-Control Studies

  2012cites this paper
• Applying epigenetics to Alzheimer's disease via the latent early-life associated regulation (LEARn) model.

  2012cites this paper
• The genetics of Alzheimer disease.

  2012cites this paper
• Integrative Analysis of Common Neurodegenerative Diseases Using Gene Association, Interaction Networks and mRNA Expression Data

  2012cites this paper
• Exploring the genetic architecture of late-onset Alzheimer disease in an Amish population

  2012cites this paper
• Genomics and bioinformatics strategies in the study of aging and Alzheimer disease

  2011cites this paper
• The Role of Lipoproteins/cholesterol in Genomic Instability and Chromosome Mis-segregation in Alzheimer's and Cardiovascular Disease

  2011cites this paper
• Modeling human neurodegenerative diseases in transgenic systems

  2011cites this paper
• PKR and PP1C Polymorphisms in Alzheimer’s Disease Risk

  2011cites this paper
• Down Syndrome Model of Alzheimer’s Disease: Beyond Trisomy 21Nondisjunction

  2011cites this paper
• Non-cholinergic pharmacotherapy approaches to Alzheimer's disease: the use of non-steroidal anti-inflammatory drugs.

  2011cites this paper
• PKR and PP 1 C Polymorphisms in Alzheimer ’ s Disease Risk

  2011cites this paper
• The Fox and the Rabbits—Environmental Variables and Population Genetics (1) Replication Problems in Association Studies and the Untapped Power of GWAS (2) Vitamin A Deficiency, Herpes Simplex Reactivation and Other Causes of Alzheimer's Disease

  2011cites this paper
• The Genetics of Alzheimer’s Disease and Parkinson’s Disease

  2011cites this paper
• Dementia Entanglements in a Postgenomic Era

  2011influential citation
• Postgenomics, uncertain futures, and the familiarization of susceptibility genes.

  2011cites this paper
• Structural and mechanistic commonalities of amyloid-β and the prion protein

  2011cites this paper
• No replication of genetic association between candidate polymorphisms and Alzheimer's disease.

  2011cites this paper
• Fibrillization of Human Tau Is Accelerated by Exposure to Lead via Interaction with His-330 and His-362

  2011cites this paper
• Increased Tau Phosphorylation and Beta Amyloid in the Hippocampus of Mouse Pups by Early Life Lead Exposure

  2010cites this paper
• Review Article: Genetics of Alzheimer Disease

  2010cites this paper
• Developmental Lead Exposure, Epigentics and Late Onset Alzheimer's Disease

  2010cites this paper
• Psychometric validity and reliability of the Arabic version of the Patient-Doctor Relationship Questionnaire ( PDRQ ) : Are patients satisfied with their psychiatrist ?

  2010cites this paper
• Current status on Alzheimer disease molecular genetics: from past, to present, to future

  2010cites this paper
• An Epigenetic Model for Susceptibility to Oxidative DNA Damage in the Aging Brain and Alzheimer’s Disease

  2010cites this paper
• Dual functions of beta-amyloid oligomer and fibril in Cu(II)-induced H2O2 production.

  2010cites this paper
• The future of genetic research on neurodegeneration

  2010cites this paper
• Impact of gene patents and licensing practices on access to genetic testing for Alzheimer disease

  2010cites this paper
• Nitric oxide: target for therapeutic strategies in Alzheimer's disease.

  2010cites this paper
• The future of genetic research on neurodegeneration.

  2010cites this paper
• Alzheimer's disease: the quest to understand complexity.

  2010cites this paper
• present, to future

  2010cites this paper
• No association between cytokine gene polymorphism and risk of Alzheimer's disease in Slovaks.

  2010cites this paper
• No association between CALHM1 and risk for Alzheimer dementia in a Belgian population

  2009cites this paper
• Involvement of insulin-degrading enzyme in the clearance of beta-amyloid at the blood-CSF barrier: Consequences of lead exposure

  2009cites this paper
• Proteolytic processing of the Alzheimer APP protein family during neuronal differentiation

  2009cites this paper
• [The genetics of dementias, Part 3: a molecular basis for the multifactorial inheritance of sporadic Alzheimer's disease].

  2009cites this paper
• Alzheimer's disease: No effect of the CDK5 gene on CSF biomarkers, neuropathology or disease risk.

  2009cites this paper
• Cognitive and olfactory changes in aging

  2009cites this paper
• Designer babies on tap? Medical students' attitudes to pre-implantation genetic screening

  2009cites this paper
• Neuron-Glia Interactions as Therapeutic Targets in Neurodegeneration

  2009cites this paper
• Down-regulation of Seladin-1 Increases BACE1 Levels and Activity through Enhanced GGA3 Depletion during Apoptosis*

  2009cites this paper